|
Osteoporosis
Contributing journals to this collection:
JAMA & Archives Journals
Citations 1-10 of 219 total displayed.
- Clinical Crossroads Update
Update: A 55-Year-Old Woman With Osteopenia
- Anna A. Mattson-DiCecca; Eileen E. Reynolds; Jen R. Cummings
JAMA 2009; 302: 2023-2024.
[Extract]
[Full text]
[PDF]
- Original Contributions
Cardiovascular Diseases and Risk of Hip Fracture
- Ulf Sennerby; Håkan Melhus; Rolf Gedeborg; Liisa Byberg; Hans Garmo; Anders Ahlbom; Nancy L. Pedersen; Karl Michaëlsson
JAMA 2009; 302: 1666-1673.
[Abstract]
[Full text]
[PDF]
- Editor's Correspondence
Relationship Between Bone, Fracture, and Exercise: The Key Role of Vitamin D—Reply
- Heike A. Bischoff-Ferrari; Walter C. Willett; John B. Wong; Andreas E. Stuck; Hannes B. Staehelin; E. John Orav; Anna Thoma; Douglas P. Kiel; Jana Henschkowski
Arch Intern Med 2009; 169: 1638-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Relationship Between Bone, Fracture, and Exercise: The Key Role of Vitamin D
- Cédric Annweiler; Olivier Beauchet
Arch Intern Med 2009; 169: 1638.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Zoledronic Acid Risks
- Bridget M. Kuehn
JAMA 2009; 302: 838.
[Extract]
[Full text]
[PDF]
- Original Contributions
Trends in Hip Fracture Rates in Canada
- William D. Leslie; Siobhan ODonnell; Sonia Jean; Claudia Lagacé; Peter Walsh; Christina Bancej; Suzanne Morin; David A. Hanley; Alexandra Papaioannou; for the Osteoporosis Surveillance Expert Working Group
JAMA 2009; 302: 883-889.
[Abstract]
[Full text]
[PDF]
- Corrections
Errors in Abstract, Text, and Table in: Albuminuria and Risk of Nonvertebral Fractures
-
Arch Intern Med 2009; 169: 707.
[Full text]
[PDF]
- Letters
5- Reductase Inhibitors and Risk of Hip Fracture—Reply
- Steven J. Jacobsen; Jiaxiao M. Shi; Ronald K. Loo
JAMA 2009; 301: 935-a.
[Extract]
[Full text]
[PDF]
- Letters
5- Reductase Inhibitors and Risk of Hip Fracture
- Madhavi Bollu; Andres C. Marte-Grau; Ravi K. Bobba
JAMA 2009; 301: 935.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Long-term Risks of Bisphosphonates Probed
- Bridget M. Kuehn
JAMA 2009; 301: 710-711.
[Extract]
[Full text]
[PDF]
|
|